Pamela P. Palmer, Chief Medical Officer at ACELRX PHARMACEUTICALS INC (ACRX), bought 840 shares at $2.81 ($2K) on 2019-02-28, disclosed to the SEC on 2019-03-04.
Open-market purchase of $2k ACRX by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ACRX | BUY | 2018-08-06 | $102K | — | Filing → |
| ACRX | BUY | 2017-08-22 | $30K | — | Filing → |
| ACRX | BUY | 2011-06-13 | $41K | — | Filing → |